EXICURE, INC.

XCUR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $0 $500.0K $0 $28.8M $-483.0K $16.6M $1.3M $118.0K
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $3.3M $0 $1.4M $19.8M $49.0M $32.1M $19.3M $14.1M
SG&A Expense $6.8M $5.4M $11.7M $10.9M $13.1M $10.0M $8.6M $7.8M
Operating Income $-4.2M $-12.2M $-15.0M $-1.8M $-62.5M $-25.4M $-26.6M $-21.8M
Operating Margin -2,446.4% -6.4% 12,950.1% -153.1% -2,053.8% -18,490.7%
Interest Expense $0 $595.0K $1.7M $573.0K $786.0K $672.0K
Pretax Income $-5.6M $-9.7M $-16.9M $-2.4M $-64.1M $-24.7M $-26.3M
Income Tax Expense $-634.0K $8.0K $0 $209.0K $0 $0 $0 $0
Net Income $-4.9M $-9.7M $-16.9M $-2.6M $-64.1M $-24.7M $-26.3M $-22.4M
Net Margin -1,940.2% -9.0% 13,271.6% -148.5% -2,029.6% -18,994.1%
EPS (Basic) $-0.79 $-1.58 $-3.52 $-0.19 $-7.23 $-0.09 $-0.15 $-0.18
EPS (Diluted) $-0.79 $-1.58 $-3.52 $-0.19 $-7.23 $-0.09 $-0.15 $-0.18
Shares Outstanding (Basic) 6.3M 6.1M 4.8M 13.9M 8.9M 261.6M 258.2M 133.1M
Shares Outstanding (Diluted) 6.3M 6.1M 4.8M 13.9M 8.9M 261.6M 258.2M 133.1M
Dividends Per Share
← Newer Page 1 of 2 Older →